A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients

Iris J. H. van Vlodrop, Sophie C. Joosten, Tim De Meyer, Kim M. Smits, Leander Van Neste, Veerle Melotte, Marcella M. L. L. Baldewijns, Leo J. Schouten, Piet A. van den Brandt, Jana Jeschke, Joo Mi Yi, Kornel E. Schuebel, Nita Ahuja, James G. Herman, Maureen J. Aarts, Fred T. Bosman, Wim Van Criekinge, Manon van Engeland*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2006-2018
Number of pages13
JournalClinical Cancer Research
Volume23
Issue number8
DOIs
Publication statusPublished - 15 Apr 2017

Keywords

  • CPG ISLAND HYPERMETHYLATION
  • HIPPEL-LINDAU GENE
  • CARCINOMA
  • MUTATIONS
  • EXPRESSION
  • PROGNOSIS
  • INACTIVATION
  • NETHERLANDS
  • EVOLUTION
  • RECEPTOR

Cite this